Volume 22, Number 8—August 2016
Research
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
Figure 3

Figure 3. Laboratory values over time for exemplary patients with and without posttreatment hemolysis after treatment with oral artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria. A) Patient without posttreatment hemolysis, B) patient with compensated posttreatment hemolysis, and C) patient with uncompensated posttreatment hemolysis. Hb, hemoglobin; LDH, lactate dehydrogenase.
Page created: July 15, 2016
Page updated: July 15, 2016
Page reviewed: July 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.